How common is Colon cancer?

Cé chomh coitianta is atá ailse colon?

Tá ailse colon, ar a dtugtar ailse colorectal freisin, ar cheann de na cineálacha ailse is coitianta ar fud an domhain.

De réir an Chiste Idirnáisiúnta um Thaighde Ailse Domhanda, is é ailse colorectal an tríú ailse is coitianta i bhfear agus an dara ailse is coitianta i mban.

I 2020, bhí meastachán ann go raibh 1.9 milliún cás nua de ailse colorectal diagnóisithe go domhanda.

Athraíonn minicíocht ailse colon de réir réigiúin, le rátaí níos airde i dtíortha forbartha mar na Stáit Aontaithe, an Eoraip, agus an Astráil, agus rátaí níos ísle i dtíortha i mbéal forbartha.

Is é an baol go dtarlóidh ailse colon ar feadh an tsaoil sna Stáit Aontaithe thart ar 1 i 23 d'fhir agus 1 i 25 do mhná.

Mar sin féin, tá an t-ionsaí foriomlán de ailse colon ag titim le blianta beaga anuas, is dócha mar gheall ar scagadh níos mó agus ar bhrath go luath.

Tagairtí

PubMed/Medline https://www.nlm.nih.gov/databases/download/pubmed_medline.html

RefinedWeb https://arxiv.org/abs/2306.01116

Chow WH, Devesa SS, Blot WJ: Colon cancer incidence: recent trends in the United States. Cancer Causes Control. 1991, 2 (6): 419-25.

Gatta G, Capocaccia R, Berrino F, Ruzza MR, Contiero P: Colon cancer prevalence and estimation of differing care needs of colon cancer patients. Ann Oncol. 2004, 15 (7): 1136-42.

Fengju S, Guanglin W, Kexin C: Incidence of colon cancer in Tianjin, China, 1981-2000. Asia Pac J Public Health. 2005, 17 (1): 22-5.

Lin PY, Fung CY, Chang FP, Huang WS, Chen WC, Wang JY, Chang D: Prevalence and genotype identification of human JC virus in colon cancer in Taiwan. J Med Virol. 2008, 80 (10): 1828-34.

Tang C, Fu S, She D, Zhou J, Su W, Zeng T: Effects of Anesthetics on Proliferation and Apoptosis of Drug-Resistant Human Colon Cancer Cells. Biomed Res Int. 2022, 2022 (): 4080585.

Wolin KY, Patel AV, Campbell PT, Jacobs EJ, McCullough ML, Colditz GA, Gapstur SM: Change in physical activity and colon cancer incidence and mortality. Cancer Epidemiol Biomarkers Prev. 2010, 19 (12): 3000-4.

Diúltú freagrachta: leighis

Cuirtear an suíomh gréasáin seo ar fáil chun críocha oideachais agus faisnéise amháin agus ní sholáthraíonn sé comhairle leighis nó seirbhísí gairmiúla.

Níor cheart an t-eolas a chuirtear ar fáil a úsáid chun fadhb sláinte nó galar a dhiagnóisiú nó a chóireáil, agus ba cheart dóibh siúd atá ag lorg comhairle leighis phearsanta dul i gcomhairle le dochtúir ceadúnaithe.

Tabhair faoi deara le do thoil go bhfuil an líonra néarónach a ghineann freagraí ar na ceisteanna, míchruinn go háirithe nuair a bhaineann sé le hábhar uimhriúil. Mar shampla, líon na ndaoine a ndearnadh diagnóis orthu le galar ar leith.

Déan comhairle do dhochtúir nó do sholáthraí sláinte cáilithe eile i gcónaí maidir le riocht leighis. Ná déan neamhaird ar chomhairle leighis ghairmiúil ná déileáil leis mar gheall ar rud éigin a léigh tú ar an suíomh Gréasáin seo. Má cheapann tú go bhféadfadh éigeandáil leighis a bheith agat, glaoigh ar 911 nó téigh go dtí an seomra éigeandála is gaire láithreach. Ní chruthaíonn an suíomh Gréasáin seo ná a úsáid aon chaidreamh dochtúir-othar. Ní dhéanann BioMedLib ná a chuid fostaithe, ná aon ranníocóir leis an suíomh Gréasáin seo aon ionadaíochtaí, sainráite nó intuigthe, maidir leis an bhfaisnéis a sholáthraítear anseo ná a úsáid.

Diúltú freagrachta: cóipchirt

Soláthraíonn an Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (an DMCA) aisíocaíocht do úinéirí cóipchirt a chreideann go sáraíonn ábhar atá le feiceáil ar an Idirlíon a gcearta faoi dhlí cóipchirt na Stát Aontaithe.

Má chreideann tú go dea-chreidimh go sáraíonn aon ábhar nó ábhar a chuirtear ar fáil i ndáil lenár suíomh Gréasáin nó lenár seirbhísí do chóipcheart, féadfaidh tú (nó do ghníomhaire) fógra a sheoladh chugainn ag iarraidh an t-ábhar nó an t-ábhar a bhaint, nó rochtain air a bhac.

Ní mór fógraí a sheoladh i scríbhinn trí ríomhphost (féach an rannán "Contact" le haghaidh seoladh ríomhphoist).

Éilíonn an DMCA go gcuimsíonn do fhógra faoi shárú cóipchirt líomhain an fhaisnéis seo a leanas: (1) cur síos ar an saothar cóipchirt atá ina ábhar don shárú líomhain; (2) cur síos ar an ábhar líomhain atá ag sárú líomhain agus faisnéis leordhóthanach chun ligean dúinn an t-ábhar a aimsiú; (3) faisnéis teagmhála duit, lena n-áirítear do sheoladh, uimhir theileafóin agus seoladh ríomhphoist; (4) ráiteas uait go bhfuil creideamh maith agat nach bhfuil an t-ábhar ar an mbealach a bhfuil gearán á dhéanamh air údaraithe ag úinéir cóipchirt, nó a ghníomhaire, nó ag oibriú aon dlí;

(5) ráiteas uait, arna shíniú faoi phionós perjury, go bhfuil an t-eolas sa fhógra cruinn agus go bhfuil an t-údarás agat na cóipchearta a éilítear a shárú a fhorfheidhmiú;

agus (6) síntiús fisiciúil nó leictreonach úinéir an chóipchirt nó duine údaraithe chun gníomhú thar ceann úinéir an chóipchirt.

D'fhéadfadh moill a bheith ar phróiseáil do ghearán mura gcuirfidh tú an t-eolas thuas go léir san áireamh.

Cumarsáid

Seol ríomhphost dúinn le haon cheist / moladh le do thoil.

How common is colon cancer?

Colon cancer, also known as colorectal cancer, is one of the most common types of cancer worldwide.

According to the World Cancer Research Fund International, colorectal cancer is the third most common cancer in men and the second most common cancer in women.

In 2020, there were an estimated 1.9 million new cases of colorectal cancer diagnosed globally.

The incidence of colon cancer varies by region, with higher rates in developed countries such as the United States, Europe, and Australia, and lower rates in developing countries.

The lifetime risk of developing colon cancer in the United States is about 1 in 23 for men and 1 in 25 for women.

However, the overall incidence of colon cancer has been declining in recent years, likely due to increased screening and early detection.

Disclaimer: medical

This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.

The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.

Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.

Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.

Disclaimer: copyright

The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.